Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for the Treatment of Single Hepatocellular Carcinoma of 2 to 5 cm in Diameter: Comparison with Surgical Resection
Open Access
- 1 January 2013
- journal article
- Published by The Korean Society of Radiology in Korean Journal of Radiology
- Vol. 14 (4), 626-635
- https://doi.org/10.3348/kjr.2013.14.4.626
Abstract
To compare the effectiveness of radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) with surgical resection in patients with a single hepatocellular carcinoma (HCC) ranging from 2 to 5 cm. The study participants were enrolled over a period of 29 months and were comprised of 37 patients in a combined therapy group and 47 patients in a surgical resection group. RFA was performed the day after TACE, and surgical resection was performed by open laparotomy. The two groups were compared with respect to the length of hospital stay, rates of major complication, and rates of recurrence-free and overall survival. Major complications occurred more frequently in the surgical resection group (14.9%) than in the combined therapy group (2.7%). However, there was no statistical significance (p = 0.059). The rates of recurrence-free survival at 1, 2, 3 and 4 years were similar between the combined therapy group (89.2%, 75.2%, 69.4% and 69.4%, respectively) and the surgical resection group (81.8%, 68.5%, 68.5% and 65%, respectively) (p = 0.7962, log-rank test). The overall survival rates at 1, 2, 3 and 4 years were also similar between groups (97.3%, 86.5%, 78.4% and 78.4%, respectively, in the combined therapy group, and 95.7%, 89.4%, 84.3% and 80.3%, respectively, in the surgical resection group) (p = 0.6321, log-rank test). When compared with surgical resection for the treatment of a single HCC ranging from 2 to 5 cm, RFA combined with TACE shows similar results in terms of recurrence-free and overall survival rates.Keywords
This publication has 39 references indexed in Scilit:
- Hepatocellular carcinomas 2–3cm in diameter: Transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation aloneEuropean Journal of Radiology, 2012
- Percutaneous Radiofrequency Ablation with Multiple Electrodes for Medium-Sized Hepatocellular CarcinomasKorean Journal of Radiology, 2012
- Management of hepatocellular carcinoma: An updateHepatology, 2011
- The Minimal Ablative Margin of Radiofrequency Ablation of Hepatocellular Carcinoma (> 2 and < 5 cm) Needed to Prevent Local Tumor Progression: 3D Quantitative Assessment Using CT Image FusionAmerican Journal of Roentgenology, 2010
- Percutaneous Radiofrequency Ablation for the Hepatocellular Carcinoma Abutting the Diaphragm: Assessment of Safety and Therapeutic EfficacyKorean Journal of Radiology, 2009
- Percutaneous Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in the Hepatic Dome: Initial ExperienceAmerican Journal of Roentgenology, 2008
- Incomplete Ablation After Radiofrequency Ablation of Hepatocellular Carcinoma: Analysis of Risk Factors and Prognostic FactorsAnnals of Surgical Oncology, 2007
- Single hepatocellular carcinoma ranging from 3 to 5cm: radiofrequency ablation or resection?HPB, 2007
- Radiofrequency Ablation of Liver TumorsArchives of Surgery, 2006
- Radiofrequency thermal ablation of liver tumorsEuropean Radiology, 2005